FOLLITROPIN ALFA

FOLLITROPIN ALFA was reported 2046 times

FOLLITROPIN ALFA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AICHMOPHOBIA 1 0.5000
1 OVARIAN HYPERSTIMULATION SYNDROME 696 0.2983
2 FEMALE GENITAL TRACT TUBERCULOSIS 2 0.2857
3 ANTRAL FOLLICLE COUNT LOW 1 0.2500
4 INDETERMINATE PREGNANCY TEST RESULT 1 0.2500
5 CYSTOSARCOMA PHYLLODES 2 0.2000
6 HAEMOCONCENTRATION 19 0.1098
7 BLOOD HUMAN CHORIONIC GONADOTROPIN DECREASED 3 0.1071
8 OVARIAN HAEMORRHAGE 25 0.1055
9 OOCYTE HARVEST 2 0.1053
10 PREMATURE OVULATION 8 0.1026
11 PAROVARIAN CYST 1 0.1000
12 OVARIAN ENLARGEMENT 38 0.0992
13 POOR RESPONSE TO OVULATION INDUCTION 1 0.0909
14 MULTIPLE PREGNANCY 16 0.0894
15 OVULATION INDUCTION 1 0.0769
16 CONCENTRIC SCLEROSIS 1 0.0667
17 LATENT TETANY 1 0.0667
18 HETEROTOPIC PREGNANCY 4 0.0635
19 OVARIAN TORSION 5 0.0602
20 PREGNANCY OF UNKNOWN LOCATION 1 0.0588
21 CORNEAL LIGHT REFLEX TEST ABNORMAL 1 0.0588
22 VERTEBROBASILAR ARTERY DISSECTION 5 0.0568
23 OVARIAN HAEMATOMA 1 0.0556
24 INTRACRANIAL ARTERY DISSECTION 1 0.0526
25 ENDOMETRIAL METAPLASIA 1 0.0526
26 FAILED IN VITRO FERTILISATION 3 0.0492
27 HUMAN CHORIONIC GONADOTROPIN NEGATIVE 1 0.0476
28 OVULATION DELAYED 1 0.0476
29 HYDROSALPINX 4 0.0435
30 ENDOMETRIAL HYPOPLASIA 1 0.0417
31 ADNEXAL TORSION 13 0.0410
32 UTERINE HYPERSTIMULATION 4 0.0392
33 ILIAC VEIN THROMBOSIS 1 0.0357
34 BORDERLINE SEROUS TUMOUR OF OVARY 1 0.0323
35 OVARIAN NECROSIS 2 0.0317
36 MASTITIS BACTERIAL 2 0.0312
37 OESTRADIOL ABNORMAL 2 0.0303
38 ABORTION EARLY 3 0.0278
39 BIOCHEMICAL PREGNANCY 3 0.0278
40 BREATH SOUNDS ABSENT 3 0.0273
41 ABORTION COMPLETE 1 0.0270
42 ANTERIOR DISPLACED ANUS 1 0.0263
43 BLOOD OESTROGEN INCREASED 15 0.0255
44 ABORTION MISSED 32 0.0252
45 BLOOD LUTEINISING HORMONE INCREASED 6 0.0244
46 PELVIC FLUID COLLECTION 17 0.0241
47 TWIN PREGNANCY 20 0.0238
48 OESTRADIOL INCREASED 7 0.0233
49 INTESTINAL ADHESION LYSIS 1 0.0227
50 IN VITRO FERTILISATION 4 0.0221
51 PLASMA CELL MASTITIS 1 0.0208
52 PROTEIN S DECREASED 3 0.0203
53 CONJOINED TWINS 2 0.0202
54 KIDNEY ANGIOMYOLIPOMA 1 0.0200
55 BLOOD LUTEINISING HORMONE ABNORMAL 1 0.0196
56 MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE 3 0.0195
57 ADNEXA UTERI CYST 3 0.0185
58 PROGESTERONE INCREASED 2 0.0180
59 HEREDITARY DISORDER 1 0.0175
60 ANTI-MUELLERIAN HORMONE LEVEL DECREASED 1 0.0172
61 OVARIAN RUPTURE 2 0.0171
62 OVULATION DISORDER 2 0.0171
63 DRUG EXPOSURE BEFORE PREGNANCY 17 0.0168
64 SEPTUM PELLUCIDUM AGENESIS 1 0.0167
65 CEREBRAL DYSGENESIS 1 0.0167
66 TUBO-OVARIAN ABSCESS 4 0.0164
67 HYPOOSMOLAR STATE 2 0.0163
68 PERITONEAL HAEMORRHAGE 22 0.0159
69 OESTRADIOL DECREASED 5 0.0155
70 BLOOD FOLLICLE STIMULATING HORMONE ABNORMAL 1 0.0154
71 BLIGHTED OVUM 6 0.0153
72 BORDERLINE OVARIAN TUMOUR 1 0.0149
73 PRECIPITATE LABOUR 1 0.0149
74 AMNIORRHEXIS 1 0.0139
75 ABDOMINAL WALL DISORDER 4 0.0137
76 PULMONARY ARTERY ATRESIA 2 0.0137
77 BLADDER TAMPONADE 4 0.0132
78 INGUINAL HERNIA, OBSTRUCTIVE 1 0.0125
79 OVARIAN ADHESION 1 0.0125
80 PROPHYLAXIS 1 0.0122
81 CEREBRAL ARTERY THROMBOSIS 6 0.0117
82 BLOOD OESTROGEN ABNORMAL 2 0.0116
83 PROCEDURAL FAILURE 2 0.0112
84 FALLOPIAN TUBE PERFORATION 1 0.0111
85 HYDROMETRA 2 0.0109
86 CREATINE PHOSPHOKINASE DECREASED 1 0.0105
87 CLINICALLY ISOLATED SYNDROME 1 0.0105
88 ABORTION SPONTANEOUS INCOMPLETE 1 0.0103
89 ECTOPIC PREGNANCY 31 0.0101
90 SUPRAPUBIC PAIN 5 0.0098
91 INFECTIOUS THYROIDITIS 1 0.0098
92 PRODUCT CONTAMINATION WITH BODY FLUID 2 0.0098
93 ANOVULATORY CYCLE 2 0.0097
94 HAEMATOCRIT INCREASED 22 0.0096
95 EXTREMITY CONTRACTURE 6 0.0094
96 CHOROIDAL NEOVASCULARISATION 8 0.0093
97 POSTPARTUM DISORDER 1 0.0093
98 PELVIC CONGESTION 1 0.0092
99 HUMAN CHORIONIC GONADOTROPIN DECREASED 1 0.0090
100 HAEMORRHAGIC OVARIAN CYST 5 0.0087
101 RENAL APLASIA 6 0.0085
102 OVARIAN DISORDER 8 0.0085
103 KIDNEY DUPLEX 2 0.0083
104 HYDROURETER 3 0.0079
105 CERVICAL INCOMPETENCE 4 0.0079
106 INTRADUCTAL PAPILLOMA OF BREAST 1 0.0078
107 OVARIAN CYST RUPTURED 10 0.0078
108 ASCITES 223 0.0076
109 CONGENITAL ANOMALY IN OFFSPRING 1 0.0076
110 LABOUR INDUCTION 1 0.0074
111 LIVER TENDERNESS 2 0.0071
112 CRYPTORCHISM 8 0.0071
113 HAEMORRHAGIC ASCITES 2 0.0070
114 FALLOPIAN TUBE CANCER 1 0.0069
115 PELIOSIS HEPATIS 1 0.0069
116 GERM CELL CANCER 1 0.0069
117 FALLOPIAN TUBE DISORDER 2 0.0068
118 CHRONIC TONSILLITIS 1 0.0065
119 KIDNEY CONGESTION 1 0.0065
120 CAUDAL REGRESSION SYNDROME 1 0.0064
121 FOETAL CARDIAC DISORDER 2 0.0063
122 CHROMOSOMAL DELETION 1 0.0063
123 MALIGNANT MELANOMA STAGE II 1 0.0061
124 BENIGN HYDATIDIFORM MOLE 2 0.0060
125 OVARIAN ADENOMA 1 0.0060
126 ABORTION 17 0.0058
127 BLOOD OESTROGEN DECREASED 4 0.0057
128 BLOOD FOLLICLE STIMULATING HORMONE DECREASED 1 0.0057
129 OVARIAN FAILURE 3 0.0056
130 BLOOD LUTEINISING HORMONE DECREASED 1 0.0056
131 ADMINISTRATION SITE DISCOMFORT 1 0.0053
132 MOANING 6 0.0053
133 COMPLICATION OF PREGNANCY 4 0.0053
134 TRISOMY 18 2 0.0052
135 FOETAL HEART RATE DISORDER 1 0.0052
136 HAEMORRHAGIC CYST 2 0.0052
137 PREGNANCY TEST POSITIVE 2 0.0051
138 HEART VALVE CALCIFICATION 1 0.0050
139 PLACENTAL INSUFFICIENCY 4 0.0050
140 RETINAL DEPOSITS 1 0.0049
141 HYDROTHORAX 4 0.0048
142 ANEMBRYONIC GESTATION 1 0.0048
143 ABDOMINAL CAVITY DRAINAGE 2 0.0047
144 BACTERIA URINE IDENTIFIED 1 0.0047
145 BLOOD HUMAN CHORIONIC GONADOTROPIN INCREASED 1 0.0047
146 FEMALE REPRODUCTIVE TRACT DISORDER 1 0.0046
147 GLOSSOPTOSIS 1 0.0046
148 JUGULAR VEIN THROMBOSIS 8 0.0045
149 HEPATIC RUPTURE 1 0.0045
150 CYST RUPTURE 3 0.0044
151 INTRA-UTERINE DEATH 7 0.0044
152 CHOLESTASIS OF PREGNANCY 2 0.0043
153 CONTINUOUS POSITIVE AIRWAY PRESSURE 1 0.0043
154 ANGINA BULLOSA HAEMORRHAGICA 1 0.0043
155 PLACENTAL DISORDER 4 0.0042
156 CONGENITAL HEART VALVE DISORDER 1 0.0042
157 INTRA-ABDOMINAL HAEMORRHAGE 10 0.0042
158 PULSE ABNORMAL 10 0.0041
159 ABORTION THREATENED 2 0.0040
160 MENINGORRHAGIA 1 0.0040
161 ADNEXA UTERI PAIN 5 0.0039
162 EPILEPTIC AURA 1 0.0039
163 RUPTURED ECTOPIC PREGNANCY 3 0.0039
164 FOETAL GROWTH RETARDATION 3 0.0038
165 PLACENTA PRAEVIA 3 0.0038
166 NEOVASCULARISATION 1 0.0038
167 ANAL ATRESIA 2 0.0037
168 MATERNAL EXPOSURE BEFORE PREGNANCY 25 0.0037
169 CYTOGENETIC ABNORMALITY 4 0.0035
170 OESOPHAGEAL OEDEMA 1 0.0035
171 SUBCLAVIAN VEIN THROMBOSIS 4 0.0035
172 COMPLICATION OF DELIVERY 1 0.0035
173 SHORTENED CERVIX 1 0.0034
174 ADRENAL ADENOMA 2 0.0034
175 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 2 0.0033
176 TENSION 20 0.0033
177 FOETAL HEART RATE ABNORMAL 3 0.0032
178 DIAPHRAGMATIC HERNIA 2 0.0032
179 PROGESTERONE DECREASED 1 0.0032
180 ANOMALY OF EXTERNAL EAR CONGENITAL 1 0.0032
181 PAPILLOMA 1 0.0032
182 ARNOLD-CHIARI MALFORMATION 3 0.0031
183 RED BLOOD CELL SCHISTOCYTES PRESENT 1 0.0031
184 DEFECT CONDUCTION INTRAVENTRICULAR 1 0.0031
185 ABORTION SPONTANEOUS 123 0.0031
186 ALOPECIA TOTALIS 1 0.0030
187 SMALL FOR DATES BABY 15 0.0030
188 NEONATAL RESPIRATORY DEPRESSION 1 0.0030
189 CRANIOPHARYNGIOMA 1 0.0030
190 MENSTRUATION NORMAL 1 0.0030
191 COAGULATION TIME SHORTENED 1 0.0030
192 PREMENSTRUAL SYNDROME 4 0.0029
193 NEONATAL INFECTION 1 0.0029
194 HAEMORRHAGE IN PREGNANCY 4 0.0028
195 PRODUCT COMPOUNDING QUALITY ISSUE 1 0.0027
196 SINGLE UMBILICAL ARTERY 1 0.0027
197 LOCAL REACTION 2 0.0027
198 HYPOPROTEINAEMIA 5 0.0026
199 ARTERIAL THROMBOSIS 5 0.0026
200 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 1 0.0026
201 FACTOR V LEIDEN MUTATION 1 0.0025
202 OVARIAN CYST 25 0.0025
203 STILLBIRTH 12 0.0025
204 ENDOMETRIAL HYPERPLASIA 2 0.0025
205 BLOOD ELECTROLYTES ABNORMAL 3 0.0024
206 DELUSIONAL PERCEPTION 1 0.0024
207 CANDIDA TEST POSITIVE 1 0.0024
208 HYPOCAPNIA 1 0.0024
209 PYRAMIDAL TRACT SYNDROME 1 0.0024
210 TRISOMY 21 3 0.0024
211 MELANOMA RECURRENT 1 0.0024
212 AMAUROSIS 2 0.0024
213 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
214 GENE MUTATION IDENTIFICATION TEST POSITIVE 1 0.0024
215 APPARENT LIFE THREATENING EVENT 1 0.0024
216 RETINAL PIGMENT EPITHELIOPATHY 1 0.0023
217 OLIGURIA 14 0.0023
218 OPERATIVE HAEMORRHAGE 1 0.0022
219 CAESAREAN SECTION 26 0.0022
220 ALLERGY TEST POSITIVE 1 0.0022
221 URETERIC OBSTRUCTION 3 0.0022
222 NECROSIS ISCHAEMIC 1 0.0022
223 PELVIC INFECTION 1 0.0022
224 MENINGIOMA BENIGN 2 0.0022
225 THERAPEUTIC RESPONSE INCREASED 2 0.0021
226 PYELOCALIECTASIS 2 0.0021
227 COMA SCALE ABNORMAL 6 0.0021
228 RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
229 THROMBOPHLEBITIS 7 0.0020
230 CONGENITAL HYDROCEPHALUS 1 0.0020
231 AUTISM 2 0.0020
232 RIGHT ATRIAL DILATATION 1 0.0020
233 PREMATURE LABOUR 11 0.0019
234 SUBILEUS 4 0.0019
235 ABDOMINAL INJURY 1 0.0019
236 CARBOHYDRATE ANTIGEN 19-9 INCREASED 1 0.0019
237 FOETAL MALFORMATION 2 0.0018
238 HAEMORRHAGIC DISORDER 2 0.0018
239 AMNIOTIC FLUID VOLUME DECREASED 1 0.0018
240 HAEMORRHAGIC INFARCTION 1 0.0018
241 ANENCEPHALY 1 0.0018
242 CEREBRAL VENTRICLE DILATATION 2 0.0017
243 TREATMENT DELAYED 3 0.0017
244 RIGHT VENTRICULAR DILATATION 1 0.0017
245 ISCHAEMIC CEREBRAL INFARCTION 2 0.0017
246 DRUG EXPOSURE DURING PREGNANCY 58 0.0017
247 PREGNANCY 34 0.0017
248 MATERNAL DRUGS AFFECTING FOETUS 13 0.0017
249 INDUCED LABOUR 1 0.0017
250 ENDOMETRIOSIS 8 0.0017
251 INTRA-ABDOMINAL FLUID COLLECTION 3 0.0017
252 UTERINE POLYP 3 0.0017
253 SACRAL PAIN 1 0.0016
254 HYDROPS FOETALIS 1 0.0016
255 PLEURAL DISORDER 1 0.0016
256 BREECH PRESENTATION 2 0.0016
257 SNORING 6 0.0016
258 ENDOMETRIAL ADENOCARCINOMA 1 0.0016
259 DRUG LEVEL DECREASED 16 0.0016
260 GESTATIONAL HYPERTENSION 2 0.0015
261 FOETAL DEATH 8 0.0015
262 EXPOSURE VIA FATHER 2 0.0015
263 SCLERAL DISCOLOURATION 1 0.0015
264 ENDOMETRITIS 1 0.0015
265 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 1 0.0015
266 EFFUSION 2 0.0015
267 SPINA BIFIDA 3 0.0014
268 LEIOMYOMA 1 0.0014
269 DYSLALIA 1 0.0014
270 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
271 ASTHMATIC CRISIS 5 0.0014
272 HEMIANOPIA HOMONYMOUS 1 0.0014
273 PELVIC INFLAMMATORY DISEASE 2 0.0013
274 CHLAMYDIAL INFECTION 1 0.0013
275 QRS AXIS ABNORMAL 1 0.0013
276 POLYCYSTIC OVARIES 2 0.0013
277 BREAST FEEDING 1 0.0013
278 CROUP INFECTIOUS 1 0.0013
279 PULSE ABSENT 6 0.0013
280 HAEMOPERITONEUM 1 0.0012
281 PLEURAL EFFUSION 76 0.0012
282 PREMATURE RUPTURE OF MEMBRANES 3 0.0012
283 LEUKOCYTURIA 1 0.0012
284 OLIGOHYDRAMNIOS 4 0.0012
285 COVID-19 IMMUNISATION 1 0.0012
286 CONGENITAL CYSTIC KIDNEY DISEASE 1 0.0012
287 UTERINE HAEMORRHAGE 5 0.0012
288 LIP PRURITUS 1 0.0012
289 PATERNAL EXPOSURE DURING PREGNANCY 1 0.0012
290 HYPOPITUITARISM 2 0.0011
291 ABDOMINAL DISTENSION 120 0.0011
292 ABDOMINAL PAIN LOWER 29 0.0011
293 HYPERLEUKOCYTOSIS 1 0.0011
294 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 80 0.0011
295 CEREBRAL VENOUS THROMBOSIS 2 0.0011
296 LIGAMENT DISORDER 1 0.0011
297 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
298 ADVERSE FOOD REACTION 1 0.0011
299 CEREBRAL THROMBOSIS 3 0.0011
300 HEPATIC CONGESTION 1 0.0011
301 CROSS SENSITIVITY REACTION 1 0.0010
302 HAEMOPHILUS INFECTION 1 0.0010
303 HYPOFIBRINOGENAEMIA 1 0.0010
304 ABDOMINAL TENDERNESS 5 0.0010
305 LOW BIRTH WEIGHT BABY 8 0.0010
306 SEMEN VOLUME DECREASED 1 0.0010
307 SUDDEN HEARING LOSS 2 0.0010
308 BENIGN BREAST NEOPLASM 1 0.0010
309 INTRACARDIAC THROMBUS 3 0.0010
310 CYTOGENETIC ANALYSIS ABNORMAL 1 0.0010
311 ORTHOPNOEA 3 0.0009
312 PELVIC PAIN 17 0.0009
313 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
314 CEREBRAL ARTERY OCCLUSION 1 0.0009
315 ORCHITIS 1 0.0009
316 NORMAL NEWBORN 5 0.0009
317 DRUG EXPOSURE VIA BREAST MILK 1 0.0009
318 IMMEDIATE POST-INJECTION REACTION 1 0.0009
319 RIGHT VENTRICULAR DYSFUNCTION 1 0.0009
320 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
321 OESTROGEN RECEPTOR ASSAY POSITIVE 1 0.0009
322 LIGAMENT INJURY 1 0.0009
323 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
324 UTERINE DISORDER 2 0.0009
325 ERYTHEMA NODOSUM 3 0.0009
326 SENSE OF OPPRESSION 1 0.0008
327 PULMONARY INFARCTION 2 0.0008
328 CEREBRAL ARTERY EMBOLISM 1 0.0008
329 HAEMATOCRIT ABNORMAL 1 0.0008
330 PERSECUTORY DELUSION 2 0.0008
331 PREMATURE BABY 24 0.0008
332 DISSEMINATED TUBERCULOSIS 2 0.0008
333 HEPATOSPLENOMEGALY 2 0.0008
334 VENOUS THROMBOSIS 3 0.0008
335 FEELING GUILTY 1 0.0008
336 ANGIONEUROTIC OEDEMA 2 0.0007
337 HYDROCEPHALUS 4 0.0007
338 DEMYELINATION 3 0.0007
339 MENINGITIS VIRAL 1 0.0007
340 DEATH NEONATAL 1 0.0007
341 LIVE BIRTH 6 0.0007
342 LUNG CONSOLIDATION 2 0.0007
343 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
344 PRECANCEROUS CELLS PRESENT 1 0.0007
345 PELVIC VENOUS THROMBOSIS 1 0.0007
346 MULTIPLE CONGENITAL ABNORMALITIES 1 0.0007
347 HAEMOTHORAX 2 0.0007
348 UTERINE LEIOMYOMA 5 0.0007
349 HYPERTRIGLYCERIDAEMIA 4 0.0007
350 BRAIN HERNIATION 2 0.0007
351 INFERTILITY 1 0.0007
352 ADHESION 1 0.0007
353 LIP DRY 6 0.0007
354 HAEMOGLOBIN INCREASED 3 0.0007
355 PREMATURE SEPARATION OF PLACENTA 1 0.0006
356 LOCALISED OEDEMA 3 0.0006
357 TALIPES 2 0.0006
358 INFERTILITY FEMALE 1 0.0006
359 APNOEA 5 0.0006
360 PHARYNGEAL PARAESTHESIA 1 0.0006
361 GESTATIONAL DIABETES 3 0.0006
362 HORMONE LEVEL ABNORMAL 3 0.0006
363 RENAL CELL CARCINOMA 3 0.0006
364 INJECTION RELATED REACTION 1 0.0006
365 MATERNAL EXPOSURE DURING PREGNANCY 54 0.0006
366 GASTRIC DILATATION 1 0.0006
367 GAZE PALSY 1 0.0006
368 BLOOD AMYLASE INCREASED 1 0.0006
369 PERIORBITAL OEDEMA 3 0.0006
370 LACK OF INJECTION SITE ROTATION 1 0.0006
371 ALOPECIA AREATA 1 0.0006
372 EMBOLIC STROKE 2 0.0006
373 FIBRIN D DIMER INCREASED 2 0.0006
374 ABDOMINAL PAIN 130 0.0006
375 PUPILLARY REFLEX IMPAIRED 1 0.0005
376 INTRACRANIAL PRESSURE INCREASED 3 0.0005
377 RETINOPATHY 2 0.0005
378 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
379 IMPATIENCE 1 0.0005
380 ABORTION INDUCED 5 0.0005
381 VAGINAL HAEMORRHAGE 23 0.0005
382 MECHANICAL VENTILATION 1 0.0005
383 HYPERCOAGULATION 1 0.0005
384 RETINAL OEDEMA 1 0.0005
385 MOTION SICKNESS 1 0.0005
386 HYPERVENTILATION 3 0.0005
387 POST PROCEDURAL HAEMORRHAGE 6 0.0005
388 CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0005
389 HYPOVOLAEMIA 3 0.0005
390 EMPYEMA 1 0.0005
391 PREMATURE DELIVERY 8 0.0005
392 ARTERIOSPASM CORONARY 2 0.0005
393 HEPATOCELLULAR INJURY 7 0.0005
394 FOETAL GROWTH RESTRICTION 3 0.0005
395 NIPPLE PAIN 1 0.0005
396 CAPILLARY LEAK SYNDROME 1 0.0005
397 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
398 THYROID FUNCTION TEST ABNORMAL 2 0.0005
399 FOETAL DISTRESS SYNDROME 1 0.0005
400 BREAST PAIN 5 0.0005
401 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
402 JAW FRACTURE 1 0.0005
403 FACIAL PALSY 1 0.0005
404 CERVICAL DYSPLASIA 1 0.0005
405 CEREBELLAR SYNDROME 1 0.0005
406 ENDOMETRIAL CANCER 1 0.0005
407 ADVERSE REACTION 6 0.0005
408 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
409 SUSPECTED OFF LABEL USE 2 0.0004
410 OPTIC NEURITIS 4 0.0004
411 PERIARTHRITIS 1 0.0004
412 OVARIAN CANCER 4 0.0004
413 CARDIOVASCULAR DISORDER 11 0.0004
414 HYPERTRANSAMINASAEMIA 3 0.0004
415 FEAR OF INJECTION 3 0.0004
416 GASTROINTESTINAL TOXICITY 2 0.0004
417 GUILLAIN-BARRE SYNDROME 2 0.0004
418 DENTAL OPERATION 1 0.0004
419 INFLAMMATORY MARKER INCREASED 2 0.0004
420 HYDRONEPHROSIS 3 0.0004
421 ABNORMAL UTERINE BLEEDING 1 0.0004
422 BLOOD CHLORIDE DECREASED 1 0.0004
423 UNRESPONSIVE TO STIMULI 10 0.0004
424 LEUKOCYTOSIS 7 0.0004
425 COMPARTMENT SYNDROME 1 0.0004
426 AREFLEXIA 1 0.0004
427 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
428 ABDOMINAL MASS 1 0.0004
429 HYPONATRAEMIA 21 0.0004
430 RHINITIS 3 0.0004
431 BREAST SWELLING 1 0.0004
432 LARYNGOSPASM 1 0.0004
433 EXPOSURE DURING PREGNANCY 23 0.0004
434 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
435 ESCHERICHIA INFECTION 3 0.0004
436 DEAFNESS UNILATERAL 2 0.0004
437 PLEURITIC PAIN 1 0.0004
438 HEMIPLEGIA 3 0.0004
439 ANAL HAEMORRHAGE 1 0.0004
440 PSYCHOMOTOR RETARDATION 1 0.0004
441 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
442 HAEMATOCRIT DECREASED 7 0.0004
443 VENTRICULAR SEPTAL DEFECT 2 0.0003
444 LUNG CANCER METASTATIC 1 0.0003
445 URINE OUTPUT DECREASED 3 0.0003
446 PULMONARY PAIN 1 0.0003
447 BLOOD CULTURE POSITIVE 1 0.0003
448 FOETAL EXPOSURE DURING PREGNANCY 27 0.0003
449 TYPE 1 DIABETES MELLITUS 2 0.0003
450 CHEST DISCOMFORT 34 0.0003
451 CHEST X-RAY ABNORMAL 1 0.0003
452 BRAIN DEATH 1 0.0003
453 BLOOD CREATININE DECREASED 1 0.0003
454 TRANSAMINASES INCREASED 7 0.0003
455 PANCREATITIS ACUTE 7 0.0003
456 NEEDLE ISSUE 9 0.0003
457 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
458 BREAST ENLARGEMENT 1 0.0003
459 OTITIS MEDIA 1 0.0003
460 CYTOLYTIC HEPATITIS 1 0.0003
461 HYPOTONIA 3 0.0003
462 VAGINAL DISCHARGE 3 0.0003
463 NEOPLASM RECURRENCE 1 0.0003
464 TACHYPNOEA 4 0.0003
465 PALLOR 8 0.0003
466 MOOD ALTERED 8 0.0003
467 NEPHROTIC SYNDROME 2 0.0003
468 POLYMENORRHOEA 1 0.0003
469 CEREBRAL INFARCTION 7 0.0003
470 MASS 4 0.0003
471 INJECTION SITE DISCOMFORT 3 0.0003
472 BRONCHIOLITIS 1 0.0003
473 FACIAL PARESIS 1 0.0003
474 LUNG TRANSPLANT 1 0.0003
475 HAEMORRHAGIC DIATHESIS 1 0.0003
476 ISCHAEMIC STROKE 5 0.0003
477 SYNCOPE 28 0.0003
478 FRUSTRATION 1 0.0003
479 DECREASED ACTIVITY 3 0.0003
480 CAROTID ARTERY OCCLUSION 1 0.0003
481 HYPOMANIA 1 0.0003
482 ANAPHYLACTIC REACTION 15 0.0003
483 FEELING DRUNK 2 0.0003
484 PULMONARY MASS 4 0.0003
485 CHRONIC SINUSITIS 1 0.0003
486 GASTRITIS 7 0.0003
487 PROTEIN TOTAL DECREASED 1 0.0003
488 BREAST TENDERNESS 2 0.0003
489 AUTOIMMUNE THYROIDITIS 1 0.0003
490 PRODUCT STORAGE ISSUE 1 0.0003
491 PANIC DISORDER 1 0.0003
492 HYPOALBUMINAEMIA 2 0.0003
493 CARDIOPULMONARY FAILURE 1 0.0003
494 MULTIPLE ALLERGIES 2 0.0003
495 PATENT DUCTUS ARTERIOSUS 1 0.0003
496 ENURESIS 1 0.0002
497 BURSITIS 3 0.0002
498 HOMICIDAL IDEATION 1 0.0002
499 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
500 BODY TEMPERATURE INCREASED 5 0.0002
501 PERIPHERAL ISCHAEMIA 1 0.0002
502 ANAPHYLACTOID REACTION 1 0.0002
503 EMBOLISM 2 0.0002
504 DYSPNOEA EXERTIONAL 9 0.0002
505 FACE OEDEMA 4 0.0002
506 HYPERPYREXIA 1 0.0002
507 RETCHING 5 0.0002
508 MYDRIASIS 3 0.0002
509 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
510 SKIN HYPERPIGMENTATION 2 0.0002
511 PLATELET COUNT INCREASED 3 0.0002
512 GINGIVAL SWELLING 1 0.0002
513 LIGAMENT RUPTURE 1 0.0002
514 DYSMENORRHOEA 3 0.0002
515 TACHYCARDIA 20 0.0002
516 EYE HAEMORRHAGE 3 0.0002
517 MENINGITIS ASEPTIC 1 0.0002
518 THERAPY NON-RESPONDER 10 0.0002
519 PAPILLOEDEMA 1 0.0002
520 PULMONARY EMBOLISM 21 0.0002
521 LOSS OF CONSCIOUSNESS 28 0.0002
522 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
523 PERFORMANCE STATUS DECREASED 1 0.0002
524 APPENDICITIS 2 0.0002
525 BLOOD SODIUM DECREASED 4 0.0002
526 BLOOD PROLACTIN INCREASED 1 0.0002
527 SARCOIDOSIS 1 0.0002
528 PRODUCT PACKAGING ISSUE 2 0.0002
529 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
530 CHOLESTASIS 4 0.0002
531 AFFECT LABILITY 2 0.0002
532 INJECTION SITE HAEMATOMA 3 0.0002
533 PRESYNCOPE 5 0.0002
534 MENORRHAGIA 4 0.0002
535 HEPATOMEGALY 2 0.0002
536 BREATH SOUNDS ABNORMAL 1 0.0002
537 EXPIRED DRUG ADMINISTERED 1 0.0002
538 ANEURYSM 1 0.0002
539 PROTEIN URINE PRESENT 1 0.0002
540 HYPERKALAEMIA 7 0.0002
541 INJURY ASSOCIATED WITH DEVICE 4 0.0002
542 PETIT MAL EPILEPSY 1 0.0002
543 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
544 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
545 CEREBRAL ISCHAEMIA 1 0.0002
546 MUSCULOSKELETAL CHEST PAIN 3 0.0002
547 VENTRICULAR EXTRASYSTOLES 2 0.0002
548 CATATONIA 1 0.0002
549 DYSURIA 7 0.0002
550 POLYARTHRITIS 1 0.0002
551 HALLUCINATION, VISUAL 4 0.0002
552 SUDDEN DEATH 2 0.0002
553 HALLUCINATION, AUDITORY 3 0.0002
554 BREAST CANCER FEMALE 5 0.0002
555 IMPAIRED WORK ABILITY 4 0.0002
556 FOOD POISONING 1 0.0002
557 INJECTION SITE DISCHARGE 1 0.0002
558 OEDEMA 10 0.0002
559 GASTROINTESTINAL PAIN 2 0.0002
560 THERAPEUTIC RESPONSE DECREASED 11 0.0002
561 VOMITING 85 0.0002
562 PROCEDURAL PAIN 5 0.0002
563 PALPITATIONS 21 0.0002
564 DYSPNOEA 100 0.0002
565 INJECTION SITE BRUISING 14 0.0002
566 NEUROLOGICAL SYMPTOM 1 0.0002
567 HYPERTONIA 1 0.0002
568 EYELID OEDEMA 2 0.0002
569 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
570 CHOLECYSTITIS 2 0.0002
571 PROTHROMBIN TIME PROLONGED 1 0.0002
572 EPILEPSY 5 0.0002
573 MENISCUS INJURY 1 0.0002
574 CYST 2 0.0002
575 BACTERIAL INFECTION 3 0.0002
576 INFUSION SITE SWELLING 1 0.0002
577 BRAIN OEDEMA 2 0.0002
578 INJECTION SITE IRRITATION 2 0.0002
579 SCREAMING 1 0.0002
580 HEPATIC CYTOLYSIS 2 0.0002
581 PROCTALGIA 1 0.0002
582 ABDOMINAL DISCOMFORT 26 0.0002
583 POOR QUALITY DRUG ADMINISTERED 1 0.0002
584 INCOHERENT 1 0.0002
585 INJECTION SITE INDURATION 2 0.0002
586 DEEP VEIN THROMBOSIS 10 0.0002
587 PRODUCT PREPARATION ISSUE 1 0.0002
588 DYSGRAPHIA 1 0.0002
589 IMMUNE SYSTEM DISORDER 2 0.0002
590 PRODUCT FORMULATION ISSUE 1 0.0002
591 MALIGNANT MELANOMA 2 0.0001
592 EYE MOVEMENT DISORDER 1 0.0001
593 RESPIRATORY ARREST 4 0.0001
594 RESPIRATION ABNORMAL 1 0.0001
595 HAIR GROWTH ABNORMAL 1 0.0001
596 FORMICATION 1 0.0001
597 HUNGER 2 0.0001
598 EATING DISORDER 3 0.0001
599 PARALYSIS 2 0.0001
600 PARAESTHESIA ORAL 2 0.0001
601 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
602 GASTROENTERITIS 2 0.0001
603 ACUTE MYOCARDIAL INFARCTION 4 0.0001
604 LABORATORY TEST ABNORMAL 4 0.0001
605 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
606 HEPATOTOXICITY 3 0.0001
607 HEPATIC FUNCTION ABNORMAL 5 0.0001
608 RESPIRATORY DISORDER 4 0.0001
609 HOT FLUSH 10 0.0001
610 DRUG INTERACTION 21 0.0001
611 NAUSEA 104 0.0001
612 DISCOMFORT 8 0.0001
613 PERICARDIAL EFFUSION 3 0.0001
614 CONGENITAL ANOMALY 1 0.0001
615 CONCUSSION 1 0.0001
616 APHTHOUS ULCER 1 0.0001
617 ACUTE MYELOID LEUKAEMIA 2 0.0001
618 MENINGIOMA 2 0.0001
619 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
620 AFFECTIVE DISORDER 1 0.0001
621 PNEUMOTHORAX 2 0.0001
622 BLOOD ALBUMIN DECREASED 1 0.0001
623 MOOD SWINGS 4 0.0001
624 ABSCESS 2 0.0001
625 HAEMORRHAGE 13 0.0001
626 SENSORY LOSS 1 0.0001
627 UNDERDOSE 9 0.0001
628 LIVER INJURY 3 0.0001
629 POLYURIA 1 0.0001
630 ABNORMAL FAECES 1 0.0001
631 VENTRICULAR TACHYCARDIA 2 0.0001
632 PRODUCT USE IN UNAPPROVED INDICATION 30 0.0001
633 INJECTION SITE ERYTHEMA 15 0.0001
634 DRUG LEVEL INCREASED 2 0.0001
635 ACUTE CORONARY SYNDROME 1 0.0001
636 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
637 BREAST CANCER STAGE II 1 0.0001
638 COAGULOPATHY 2 0.0001
639 URINARY RETENTION 4 0.0001
640 CIRCULATORY COLLAPSE 2 0.0001
641 HAEMATURIA 4 0.0001
642 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
643 PRODUCT CONTAINER ISSUE 1 0.0001
644 ANAPHYLACTIC SHOCK 3 0.0001
645 ANURIA 1 0.0001
646 HAEMATOMA 3 0.0001
647 PYELONEPHRITIS 1 0.0001
648 DELIRIUM 4 0.0001
649 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
650 AMENORRHOEA 2 0.0001
651 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
652 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
653 HAEMOLYTIC ANAEMIA 1 0.0001
654 HEAVY MENSTRUAL BLEEDING 1 0.0001
655 BLOOD BILIRUBIN INCREASED 3 0.0001
656 OROPHARYNGEAL DISCOMFORT 1 0.0001
657 CRYING 4 0.0001
658 C-REACTIVE PROTEIN INCREASED 4 0.0001
659 BRAIN NEOPLASM 1 0.0001
660 RESPIRATORY DISTRESS 3 0.0001
661 GRAND MAL CONVULSION 1 0.0001
662 THINKING ABNORMAL 2 0.0001
663 BREAST CANCER 10 0.0001
664 ERYTHEMA MULTIFORME 1 0.0001
665 HEPATIC ENCEPHALOPATHY 1 0.0001
666 HAEMOGLOBIN DECREASED 11 0.0001
667 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
668 RECALLED PRODUCT ADMINISTERED 1 0.0001
669 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
670 MULTIPLE SCLEROSIS 5 0.0001
671 INJECTION SITE PRURITUS 7 0.0001
672 POST PROCEDURAL COMPLICATION 2 0.0001
673 ATELECTASIS 1 0.0001
674 LIVER FUNCTION TEST ABNORMAL 3 0.0001
675 EAR PAIN 2 0.0001
676 CHOKING 2 0.0001
677 INJECTION SITE REACTION 7 0.0001
678 PARAESTHESIA 16 0.0001
679 BODY TEMPERATURE DECREASED 1 0.0001
680 LIGAMENT SPRAIN 1 0.0001
681 MALAISE 44 0.0001
682 INJECTION SITE HAEMORRHAGE 8 0.0001
683 APHASIA 3 0.0001
684 HYPOTHERMIA 1 0.0001
685 TASTE DISORDER 2 0.0001
686 DRY THROAT 1 0.0001
687 FLUID RETENTION 5 0.0001
688 INJECTION SITE RASH 3 0.0001
689 EAR DISCOMFORT 1 0.0001
690 EMOTIONAL DISORDER 3 0.0001
691 GYNAECOMASTIA 3 0.0001
692 LIMB DISCOMFORT 3 0.0001
693 CARDIAC ARREST 8 0.0001
694 HYPERBILIRUBINAEMIA 1 0.0001
695 SPEECH DISORDER 5 0.0001
696 SEIZURE 11 0.0001
697 PANCREATITIS 5 0.0001
698 DEPRESSED MOOD 5 0.0001
699 RENAL PAIN 1 0.0001
700 RENAL FAILURE ACUTE 4 0.0001
701 POOR QUALITY SLEEP 2 0.0001
702 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
703 VIRAL INFECTION 3 0.0001
704 LIP SWELLING 3 0.0001
705 HYPERTENSIVE CRISIS 1 0.0001
706 MALNUTRITION 1 0.0001
707 HEPATIC ENZYME INCREASED 6 0.0001
708 INTERNAL HAEMORRHAGE 1 0.0001
709 MYOCARDITIS 1 0.0001
710 SHOCK 2 0.0001
711 METASTASES TO LUNG 1 0.0001
712 MADAROSIS 1 0.0001
713 OFF LABEL USE 75 0.0001
714 DEVICE MALFUNCTION 6 0.0001
715 HEADACHE 53 0.0001
716 TREATMENT FAILURE 7 0.0001
717 ARRHYTHMIA 4 0.0001
718 SOMNOLENCE 17 0.0001
719 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
720 MIGRAINE 8 0.0001
721 MUSCLE RIGIDITY 1 0.0001
722 NEURALGIA 2 0.0001
723 RESTLESSNESS 3 0.0001
724 MUSCLE SPASTICITY 1 0.0001
725 INJECTION SITE EXTRAVASATION 1 0.0001
726 HYPERCALCAEMIA 1 0.0001
727 ABNORMAL WEIGHT GAIN 1 0.0001
728 GENERALISED OEDEMA 1 0.0001
729 WEIGHT INCREASED 18 0.0001
730 HAIR COLOUR CHANGES 1 0.0001
731 INJECTION SITE SWELLING 6 0.0001
732 HYPOPHAGIA 2 0.0001
733 HEPATITIS 2 0.0001
734 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
735 RASH GENERALISED 2 0.0001
736 EXPOSURE VIA SKIN CONTACT 2 0.0001
737 NODULE 1 0.0001
738 INCORRECT PRODUCT STORAGE 1 0.0001
739 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
740 BRADYCARDIA 4 0.0001
741 EAR INFECTION 2 0.0001
742 HAIR TEXTURE ABNORMAL 1 0.0001
743 THROMBOSIS 6 0.0001
744 QUALITY OF LIFE DECREASED 1 0.0001
745 PRODUCT USE ISSUE 14 0.0001
746 SINUS CONGESTION 1 0.0001
747 THROAT TIGHTNESS 2 0.0001
748 HYPOAESTHESIA 11 0.0001
749 GINGIVAL BLEEDING 1 0.0001
750 LUNG NEOPLASM MALIGNANT 3 0.0001
751 CONDITION AGGRAVATED 22 0.0001
752 ACUTE KIDNEY INJURY 11 0.0001
753 BLOOD TEST ABNORMAL 1 0.0001
754 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
755 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
756 BLINDNESS UNILATERAL 1 0.0001
757 HEART RATE INCREASED 7 0.0001
758 FLATULENCE 4 0.0001
759 DIALYSIS 1 0.0001
760 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
761 INCORRECT DOSE ADMINISTERED 16 0.0001
762 BRONCHOSPASM 1 0.0001
763 CARDIOGENIC SHOCK 1 0.0001
764 ASTHENIA 26 0.0001
765 MYELODYSPLASTIC SYNDROME 1 0.0001
766 HYPERTHYROIDISM 1 0.0001
767 DECREASED APPETITE 16 0.0001
768 ANAEMIA 13 0.0001
769 ANGIOEDEMA 3 0.0001
770 PSYCHOTIC DISORDER 2 0.0001
771 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
772 IMMUNODEFICIENCY 1 0.0001
773 DEVICE ISSUE 6 0.0001
774 HYPOAESTHESIA ORAL 1 0.0001
775 HYPERTENSION 14 0.0001
776 BLOOD COUNT ABNORMAL 1 0.0001
777 DEVICE FAILURE 1 0.0001
778 MUSCLE SPASMS 12 0.0001
779 INJECTION SITE PAIN 20 0.0001
780 DRUG ADMINISTRATION ERROR 2 0.0001
781 ADVERSE EVENT 6 0.0001
782 PHARYNGEAL OEDEMA 1 0.0001
783 CHEST PAIN 12 0.0001
784 HYPERSENSITIVITY 12 0.0001
785 DELUSION 1 0.0001
786 INSOMNIA 17 0.0001
787 DRUG-INDUCED LIVER INJURY 2 0.0001
788 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
789 HYPOTHYROIDISM 2 0.0001
790 HYPOGLYCAEMIA 3 0.0001
791 BLOOD POTASSIUM INCREASED 1 0.0001
792 MANIA 1 0.0001
793 PYREXIA 21 0.0001
794 BACK PAIN 14 0.0001
795 CYTOMEGALOVIRUS INFECTION 1 0.0001
796 DEHYDRATION 8 0.0001
797 PERICARDITIS 1 0.0001
798 TYPE 2 DIABETES MELLITUS 2 0.0001
799 DRUG INEFFECTIVE 78 0.0001
800 HEMIPARESIS 1 0.0001
801 METRORRHAGIA 1 0.0001
802 MUSCULOSKELETAL DISCOMFORT 1 0.0001
803 MULTI-ORGAN FAILURE 1 0.0001
804 LOCAL SWELLING 1 0.0001
805 MUSCULOSKELETAL PAIN 3 0.0001
806 METASTASES TO LIVER 1 0.0001
807 DERMATITIS ATOPIC 3 0.0001
808 COLD SWEAT 1 0.0001
809 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
810 PANIC ATTACK 2 0.0001
811 ACCIDENTAL OVERDOSE 2 0.0001
812 FEELING ABNORMAL 13 0.0001
813 URTICARIA 9 0.0001
814 NECK PAIN 3 0.0001
815 SWELLING 5 0.0001
816 OXYGEN SATURATION DECREASED 3 0.0001
817 MYALGIA 9 0.0001
818 HYPOCALCAEMIA 1 0.0001
819 FRACTURE 1 0.0001
820 GASTRIC ULCER 1 0.0001
821 PROTEINURIA 1 0.0001
822 MUSCULOSKELETAL DISORDER 1 0.0001
823 INCREASED APPETITE 1 0.0001
824 HAEMORRHOIDS 1 0.0001
825 CHILLS 6 0.0001
826 NASAL CONGESTION 3 0.0001
827 DYSPEPSIA 5 0.0001
828 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
829 ABNORMAL BEHAVIOUR 2 0.0001
830 DISORIENTATION 2 0.0001
831 BLOOD PRESSURE ABNORMAL 1 0.0001
832 PRESCRIBED UNDERDOSE 1 0.0001
833 BONE MARROW FAILURE 1 0.0000
834 ANXIETY 14 0.0000
835 ABDOMINAL PAIN UPPER 10 0.0000
836 RHABDOMYOLYSIS 2 0.0000
837 POLLAKIURIA 2 0.0000
838 RENAL IMPAIRMENT 4 0.0000
839 FATIGUE 37 0.0000
840 MOUTH ULCERATION 1 0.0000
841 JOINT INJURY 1 0.0000
842 LIVER FUNCTION TEST INCREASED 1 0.0000
843 HYPERHIDROSIS 6 0.0000
844 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
845 AMNESIA 3 0.0000
846 SWELLING FACE 3 0.0000
847 BLOOD CREATININE INCREASED 3 0.0000
848 LIVER DISORDER 2 0.0000
849 RASH MACULO-PAPULAR 1 0.0000
850 THROMBOCYTOPENIA 5 0.0000
851 PULMONARY OEDEMA 2 0.0000
852 ASTHMA 5 0.0000
853 DIZZINESS 22 0.0000
854 SUICIDAL IDEATION 4 0.0000
855 OROPHARYNGEAL PAIN 4 0.0000
856 BURNING SENSATION 3 0.0000
857 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
858 DIABETIC KETOACIDOSIS 1 0.0000
859 CEREBROVASCULAR ACCIDENT 7 0.0000
860 RESPIRATORY FAILURE 3 0.0000
861 ARTHRALGIA 17 0.0000
862 PAIN 25 0.0000
863 ABASIA 1 0.0000
864 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
865 UNEVALUABLE EVENT 3 0.0000
866 BLOOD PRESSURE INCREASED 6 0.0000
867 HOSPITALISATION 6 0.0000
868 SINUSITIS 4 0.0000
869 DIARRHOEA 25 0.0000
870 SEDATION 1 0.0000
871 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
872 JAUNDICE 1 0.0000
873 DISTURBANCE IN ATTENTION 2 0.0000
874 FREQUENT BOWEL MOVEMENTS 1 0.0000
875 RASH PRURITIC 2 0.0000
876 PRODUCT QUALITY ISSUE 5 0.0000
877 CONSTIPATION 8 0.0000
878 INFLUENZA LIKE ILLNESS 3 0.0000
879 VISION BLURRED 5 0.0000
880 DIVERTICULITIS 1 0.0000
881 MEDICATION ERROR 2 0.0000
882 FEELING COLD 1 0.0000
883 INFLUENZA 4 0.0000
884 WEIGHT DECREASED 10 0.0000
885 EYE PAIN 2 0.0000
886 MUSCULAR WEAKNESS 4 0.0000
887 RASH 15 0.0000
888 PRODUCT STORAGE ERROR 3 0.0000
889 DYSSTASIA 1 0.0000
890 MUSCULOSKELETAL STIFFNESS 3 0.0000
891 SURGERY 2 0.0000
892 ERYTHEMA 7 0.0000
893 PAIN IN EXTREMITY 10 0.0000
894 IRRITABILITY 2 0.0000
895 BLOOD POTASSIUM DECREASED 1 0.0000
896 HEPATIC FAILURE 1 0.0000
897 SUICIDE ATTEMPT 2 0.0000
898 OEDEMA PERIPHERAL 4 0.0000
899 FEELING HOT 2 0.0000
900 PERIPHERAL SWELLING 5 0.0000
901 VISUAL IMPAIRMENT 4 0.0000
902 BONE DENSITY DECREASED 1 0.0000
903 BLOOD PRESSURE DECREASED 2 0.0000
904 EXPIRED PRODUCT ADMINISTERED 1 0.0000
905 NEOPLASM MALIGNANT 2 0.0000
906 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
907 SLEEP DISORDER 2 0.0000
908 LYMPHADENOPATHY 1 0.0000
909 MOBILITY DECREASED 2 0.0000
910 NASOPHARYNGITIS 5 0.0000
911 INJECTION SITE MASS 1 0.0000
912 DYSARTHRIA 1 0.0000
913 ACNE 2 0.0000
914 PRURITUS 10 0.0000
915 COUGH 7 0.0000
916 HYPOTENSION 5 0.0000
917 CARDIAC FAILURE 2 0.0000
918 PNEUMONIA 8 0.0000
919 BLINDNESS 1 0.0000
920 FALL 8 0.0000
921 CARDIO-RESPIRATORY ARREST 1 0.0000
922 HYPOACUSIS 1 0.0000
923 SEPTIC SHOCK 1 0.0000
924 MENTAL DISORDER 1 0.0000
925 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
926 RENAL FAILURE 3 0.0000
927 DRY SKIN 3 0.0000
928 SKIN DISCOLOURATION 1 0.0000
929 COGNITIVE DISORDER 1 0.0000
930 DYSPHAGIA 2 0.0000
931 DISEASE RECURRENCE 1 0.0000
932 PRODUCTIVE COUGH 1 0.0000
933 RASH ERYTHEMATOUS 1 0.0000
934 BLOOD GLUCOSE DECREASED 1 0.0000
935 CONTUSION 2 0.0000
936 INFECTION 3 0.0000
937 DRUG INTOLERANCE 2 0.0000
938 LUNG DISORDER 1 0.0000
939 ALOPECIA 4 0.0000
940 AGGRESSION 1 0.0000
941 CELLULITIS 1 0.0000
942 ILLNESS 2 0.0000
943 PLATELET COUNT DECREASED 2 0.0000
944 DRUG EFFECT DECREASED 1 0.0000
945 CONFUSIONAL STATE 3 0.0000
946 OVERDOSE 4 0.0000
947 BLISTER 1 0.0000
948 URINARY TRACT INFECTION 3 0.0000
949 DEPRESSION 4 0.0000
950 LETHARGY 1 0.0000
951 DYSPHONIA 1 0.0000
952 BONE PAIN 1 0.0000
953 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
954 JOINT SWELLING 2 0.0000
955 NO ADVERSE EVENT 3 0.0000
956 ILL-DEFINED DISORDER 1 0.0000
957 DEVICE EXPULSION 1 0.0000
958 PRODUCT DOSE OMISSION 1 0.0000
959 DEVICE DIFFICULT TO USE 1 0.0000
960 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
961 NEUTROPENIA 2 0.0000
962 MEMORY IMPAIRMENT 2 0.0000
963 SKIN BURNING SENSATION 1 0.0000
964 AGITATION 1 0.0000
965 BRONCHITIS 1 0.0000
966 DYSGEUSIA 1 0.0000
967 CHRONIC KIDNEY DISEASE 1 0.0000
968 ARTHRITIS 1 0.0000
969 TREMOR 2 0.0000
970 SKIN EXFOLIATION 1 0.0000
971 BALANCE DISORDER 1 0.0000
972 MYOCARDIAL INFARCTION 2 0.0000
973 GASTROINTESTINAL DISORDER 1 0.0000
974 ADVERSE DRUG REACTION 1 0.0000
975 CARDIAC DISORDER 1 0.0000
976 BLOOD GLUCOSE INCREASED 2 0.0000
977 NEUROPATHY PERIPHERAL 1 0.0000
978 GAIT DISTURBANCE 2 0.0000
979 PRODUCT DOSE OMISSION ISSUE 3 0.0000
980 FLUSHING 1 0.0000
981 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
982 SEPSIS 1 0.0000
983 EMOTIONAL DISTRESS 1 0.0000
984 PSORIASIS 1 0.0000
985 COVID-19 1 0.0000
986 DEATH 2 0.0000